Clinical Trial Update: Sentinel Lymph Node Biopsy After Neoadjuvant Treatment in Breast Cancer Patents

View source ↗

Summary

The clinical trial NCT03719833 assessing sentinel lymph node biopsy after neoadjuvant treatment in breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Clinical Hospital Center Rijeka | Conditions: Breast Cancer, Sentinel Lymph Node Biopsy | Status: COMPLETED